Trends and Risk Factors of In-Hospital Mortality of Patients with COVID-19 in Germany: Results of a Large Nationwide Inpatient Sample
- PMID: 35215869
- PMCID: PMC8880622
- DOI: 10.3390/v14020275
Trends and Risk Factors of In-Hospital Mortality of Patients with COVID-19 in Germany: Results of a Large Nationwide Inpatient Sample
Abstract
Unselected data of nationwide studies of hospitalized patients with COVID-19 are still sparse, but these data are of outstanding interest to avoid exceeding hospital capacities and overloading national healthcare systems. Thus, we sought to analyze seasonal/regional trends, predictors of in-hospital case-fatality, and mechanical ventilation (MV) in patients with COVID-19 in Germany. We used the German nationwide inpatient samples to analyze all hospitalized patients with a confirmed COVID-19 diagnosis in Germany between 1 January and 31 December in 2020. We analyzed data of 176,137 hospitalizations of patients with confirmed COVID-19-infection. Among those, 31,607 (17.9%) died, whereby in-hospital case-fatality grew exponentially with age. Overall, age ≥ 70 years (OR 5.91, 95%CI 5.70-6.13, p < 0.001), pneumonia (OR 4.58, 95%CI 4.42-4.74, p < 0.001) and acute respiratory distress syndrome (OR 8.51, 95%CI 8.12-8.92, p < 0.001) were strong predictors of in-hospital death. Most COVID-19 patients were treated in hospitals in urban areas (n = 92,971) associated with the lowest case-fatality (17.5%), as compared to hospitals in suburban (18.3%) or rural areas (18.8%). MV demand was highest in November/December 2020 (32.3%, 20.3%) in patients between the 6th and 8th age decade. In the first age decade, 78 of 1861 children (4.2%) with COVID-19-infection were treated with MV, and five of them died (0.3%). The results of our study indicate seasonal and regional variations concerning the number of COVID-19 patients, necessity of MV, and case fatality in Germany. These findings may help to ensure the flexible allocation of intensive care (human) resources, which is essential for managing enormous societal challenges worldwide to avoid overloaded regional healthcare systems.
Keywords: COVID-19; SARS-CoV2; health resources; intensive care unit; mechanical ventilation.
Conflict of interest statement
LH received lecture/consultant fees from MSD and Actelion, outside the submitted work. ISa reports no conflict of interests. SB received lecture/consultant fees from Bayer HealthCare, Concept Medical, BTG Pharmaceuticals, INARI, Boston Scientific, and LeoPharma; institutional grants from Boston Scientific, Bentley, Bayer HealthCare, INARI, Medtronic, Concept Medical, Bard, and Sanofi; and economical support for travel/congress costs from Daiichi Sankyo, BTG Pharmaceuticals, and Bayer HealthCare, outside the submitted work. ISc reports no conflict of interests. CEK reports having from Amarin Germany, Amgen GmbH, Bayer Vital, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Leo Pharma, MSD Sharp & Dohme, Novartis Pharma, Pfizer Pharma GmbH, and Sanofi-Aventis GmbH. SK reports institutional grants and personal lecture/advisory fees from Bayer AG, Daiichi Sankyo, and Boston Scientific; institutional grants from Inari Medical; and personal lecture/advisory fees from MSD and Bristol Myers Squibb/Pfizer. TM reports no conflict of interests. TM is PI of the DZHK (German Center for Cardiovascular Research), Partner Site Rhine-Main, Mainz, Germany. KK reports no conflict of interests.
Figures



Similar articles
-
Risk factors for intensive care admission in childhood patients with COVID-19 - Results of the German nationwide inpatient sample.Respir Med. 2025 Jan;236:107880. doi: 10.1016/j.rmed.2024.107880. Epub 2024 Nov 23. Respir Med. 2025. PMID: 39586334
-
Case Fatality of Hospitalized Patients with COVID-19 Infection Suffering from Acute Respiratory Distress Syndrome in Germany.Viruses. 2022 Nov 14;14(11):2515. doi: 10.3390/v14112515. Viruses. 2022. PMID: 36423124 Free PMC article.
-
Predisposing factors for admission to intensive care units of patients with COVID-19 infection-Results of the German nationwide inpatient sample.Front Public Health. 2023 Feb 15;11:1113793. doi: 10.3389/fpubh.2023.1113793. eCollection 2023. Front Public Health. 2023. PMID: 36875366 Free PMC article.
-
A Comprehensive Report of German Nationwide Inpatient Data on the Post-COVID-19 Syndrome Including Annual Direct Healthcare Costs.Viruses. 2022 Nov 22;14(12):2600. doi: 10.3390/v14122600. Viruses. 2022. PMID: 36560604 Free PMC article. Review.
-
[Managing the pandemic-relocation concept for COVID-19 intensive care patients and non-COVID-19 intensive care patients in Baden-Württemberg].Anaesthesist. 2021 Nov;70(11):951-961. doi: 10.1007/s00101-021-00961-4. Epub 2021 Apr 28. Anaesthesist. 2021. PMID: 33909104 Free PMC article. Review. German.
Cited by
-
Intensive care treatment in acute pulmonary embolism in Germany, 2016 to 2020: a nationwide inpatient database study.Res Pract Thromb Haemost. 2024 Aug 8;8(6):102545. doi: 10.1016/j.rpth.2024.102545. eCollection 2024 Aug. Res Pract Thromb Haemost. 2024. PMID: 39318771 Free PMC article.
-
Impact of biologics and small molecules for inflammatory bowel disease on COVID-19-related hospitalization and mortality: A systematic review and meta-analysis.JGH Open. 2022 Mar 20;6(4):241-250. doi: 10.1002/jgh3.12728. eCollection 2022 Apr. JGH Open. 2022. PMID: 35475207 Free PMC article.
-
COVID-19 in the years 2020 to 2022 in Germany: effects of comorbidities and co-medications based on a large-scale database analysis.BMC Public Health. 2025 Feb 8;25(1):525. doi: 10.1186/s12889-024-21110-7. BMC Public Health. 2025. PMID: 39923000 Free PMC article.
-
COVID-19 Disease Burden in the Omicron Variant-Dominated Endemic Phase: Insights from the ROUTINE-COV19 Study Using Real-World German Statutory Health Insurance Data.Viruses. 2025 Mar 14;17(3):424. doi: 10.3390/v17030424. Viruses. 2025. PMID: 40143351 Free PMC article.
-
Obesity and Its Impact on Adverse In-Hospital Outcomes in Hospitalized Patients With COVID-19.Front Endocrinol (Lausanne). 2022 May 2;13:876028. doi: 10.3389/fendo.2022.876028. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35586628 Free PMC article.
References
-
- Böhmer M.M., Buchholz U., Corman V.M., Hoch M., Katz K., Marosevic D.V., Böhm S., Woudenberg T., Ackermann N., Konrad R., et al. Investigation of a COVID-19 outbreak in Germany resulting from a single travel-associated primary case: A case series. Lancet Infect. Dis. 2020;20:920–928. doi: 10.1016/S1473-3099(20)30314-5. - DOI - PMC - PubMed
-
- Ullrich A., Schranz M., Rexroth U., Hamouda O., Schaade L., Diercke M., Boender T.S. Impact of the COVID-19 pandemic and associated non-pharmaceutical interventions on other notifiable infectious diseases in Germany: An analysis of national surveillance data during week 1–2016—week 32–2020. Lancet Reg. Health Eur. 2021;6:100103. doi: 10.1016/j.lanepe.2021.100103. - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous